$785 – $2,485

Fierce Biotech: 2nd Drug Development Forum (EXL)

Event Information

Share this event

Date and Time

Location

Location

Renaissance Boston Waterfront Hotel

606 Congress Street

Boston, MA 02210

View Map

Friends Who Are Going
Event description

Description

The FDA approved only 22 new drug candidates in 2016 — less than half of the prior year, and the lowest level since 2010. The IPO market has collapsed to its lowest level since 2009. In the face of this regulatory and financial uncertainty, biotech companies must increasingly rely on creative deal-making and the discovery of new indications for established products. But that requires an entirely new approach to partnerships and pipeline strategy, from the highest levels of biotech leadership.

The FierceBiotech 2nd Drug Development Forum is unequaled at drawing together the industry's executive decision-makers. Its purpose is to guide you towards new strategies throughout the entire life cycle - of both your product and your company.

This year's agenda features:

  • Over 75 expert speakers - nearly all at the VP level or C-suite

  • Four detailed learning tracks covering biotech partnerships for funding, clinical research, R&D outcomes, and data resources

  • Four in-depth workshops

  • Learning and networking opportunities with over 350 biotech industry leaders

Who Should Attend

This event is aimed at professionals in the pharmaceutical, biotech, medical device and venture capitalist fields responsible for:

  • Business Development
  • Corporate Development
  • Mergers and Acquisitions
  • Alliance Management
  • Partnering
  • Portfolio Management
  • Vendor Management
  • Licensing
  • Clinical Research/Clinical Development
  • Strategy/Product Strategy/Strategic Development
  • Clinical Trial Management
  • Data Management
  • Innovation
  • Investments
  • R&D
  • Regulatory Affairs
  • Patient/Medical Safety
  • Patient Centricity
  • Clinical Affairs/Operations
  • Regulatory Affairs/Compliance

This event is also of interest to:

  • CROs
  • Supply Chain Professionals
  • Law Firms
  • Clinical Data Management Specialists
  • Business Development Specialists
  • Legal

Key subject areas

  • Mergers & acquisitions to strengthen your drug pipeline
  • Remote clinical monitoring and its impact on development speed
  • The art of the biotech deal: creating syndicates and driving value
  • Building relationships and networking with KOLs
  • Prioritizing late-stage development programs
  • Optimizing teamwork with CROs for drug development
  • Biopharma alliances with venture capitalists and academic researchers
  • Avoiding the riskiest pitfalls in early outsourced biotech operations
  • Team-based approaches to securing “breakthrough” designation from FDA
  • The greatest challenges in product valuation
  • Selecting ideal partners for emerging markets and orphan / specialty drugs
  • Adapting to FDA’s “Fast Track”
  • Engaging patients to avoid pitfalls in clinical research
  • Recognizing changes in biotech funding sources and trends


FACULTY

Michael Aberman
Michael Aberman

Vice President, Strategy and Investor Relations
REGENERON

Richard Anders
Richard Anders

Founder
MASS MEDICAL ANGELS

Estuardo Aguilar
Estuardo Aguilar

CEO
ADVANTAGENE

Michael Bailey
Michael Bailey

CEO
AVEO ONCOLOGY

Roy Baynes
Roy Baynes

Senior Vice President, Head of Clinical Development
MERCK

Jeremy Bender
Jeremy Bender

COO
TIZONA THERAPEUTICS

Lewis Bender
Lewis Bender

CEO
INTENSITY THERAPEUTICS

Donald Bergstrom
Donald Bergstrom

CMO
MERSANA THERAPEUTICS

Carl Berke
Carl Berke

Partner
PARTNERS HEALTHCARE VENTURES

Kevin Bitterman
Kevin Bitterman

Partner
POLARIS PARTNERS

Steve Brannan
Steve Brannan

CMO
KARUNA PHARMACEUTICALS

Richard Brudnick
Richard Brudnick

Executive Vice President, Business Development
BIOVERATIV

David Brush
David Brush

Senior Director, Transactions
JOHNSON & JOHNSON

Christine Carberry
Christine Carberry

COO
KERYX BIOPHARMACEUTICALS

Gail Cawkwell
Gail Cawkwell

CMO
PURDUE PHARMACEUTICALS

Mike Clayman
Mike Clayman

CEO
FLEXION THERAPEUTICS

Josh Cohen
Josh Cohen

CEO
AMYLYX PHARMACEUTICALS

Michael Cola, CEO, AEVI GENOMIC MEDICINE
Michael Cola

CEO
AEVI GENOMIC MEDICINE

Laurence Cooper, CEO, ZIOPHARM
Laurence Cooper

CEO
ZIOPHARM

Heather DeBenedetto, Vice President, Head of Therapeutic Operations, MODERNA  THERAPEUTICS
Heather DeBenedetto

Vice President, Head of Therapeutic Operations
MODERNA THERAPEUTICS

Deborah Dunsire, Principal, SOUTHERN CROSS BIO
Deborah Dunsire

Principal
SOUTHERN CROSS BIO

Neal Farber, CEO, NEUROHEALING PHARMACEUTICALS
Neal Farber

CEO
NEUROHEALING PHARMACEUTICALS

Maurizio Fava, Director, Division of Clinical Research, MGH RESEARCH INSTITUTE
Maurizio Fava

Director, Division of Clinical Research
MGH RESEARCH INSTITUTE

Mitchell Finer, CEO, ONCORUS
Mitchell Finer

CEO
ONCORUS

Greg Fiore, CMO, SYNEDGEN
Greg Fiore

CMO
SYNEDGEN

Dennis Ford, CEO, LIFE SCIENCE NATION
Dennis Ford

CEO
LIFE SCIENCE NATION

Karen Gardner, Senior Director, Clinical Development Operations, SEQIRUS
Karen Gardner

Senior Director, Clinical Development Operations
SEQIRUS

Angus Grant, Vice President, Regulatory Affairs, Finance, CELGENE
Angus Grant

Vice President, Regulatory Affairs, Finance
CELGENE

Carolyn Green, Executive Director, Strategic Investments, Worldwide R&D, PFIZER
Carolyn Green

Executive Director, Strategic Investments, Worldwide R&D
PFIZER

Luba Greenwood, Vice President, Global Mergers, Acquisitions and Business  Development, ROCHE
Luba Greenwood

Vice President, Global Mergers, Acquisitions and Business Development
ROCHE

Richard Gregory, CSO, IMMUNOGEN
Richard Gregory

CSO
IMMUNOGEN

Jessica Grossman, CEO, MEDICINES360
Jessica Grossman

CEO
MEDICINES360

Dana Hilt, CMO, LYSOSOMAL THERAPEUTICS
Dana Hilt

CMO
LYSOSOMAL THERAPEUTICS

John Hohneker, Executive Vice President, Head of R&D, FORMA THERAPEUTICS
John Hohneker

Executive Vice President, Head of R&D
FORMA THERAPEUTICS

Tom Hudson, Vice President, Oncology Discovery, Early Development, ABBVIE
Tom Hudson

Vice President, Oncology Discovery, Early Development
ABBVIE

Stephen Isaacs, CEO, ADURO BIOTECH
Stephen Isaacs

CEO
ADURO BIOTECH

Eva Jack, CBO, MERSANA THERAPEUTICS
Eva Jack

CBO
MERSANA THERAPEUTICS

Kenneth Kaitin, Director, TUFTS CENTER FOR THE STUDY OF DRUG  DEVELOPMENT
Kenneth Kaitin

Director
TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT

Edward Kaye, CEO, SAREPTA THERAPEUTICS
Edward Kaye

CEO
SAREPTA THERAPEUTICS

Justin Klee, President, AMYLYX PHARMACEUTICALS
Justin Klee

President
AMYLYX PHARMACEUTICALS

Isaac Kohane, Chair, Department of Biomedical Informatics, HARVARD MEDICAL  SCHOOL
Isaac Kohane

Chair, Department of Biomedical Informatics
HARVARD MEDICAL SCHOOL

William Korinek, CEO, ASTROCYTE PHARMACEUTICALS
William Korinek

CEO
ASTROCYTE PHARMACEUTICALS

Pablo Lapuerta, Executive Vice President and CMO, LEXICON PHARMACEUTICALS
Pablo Lapuerta

Executive Vice President and CMO
LEXICON PHARMACEUTICALS

Liz Lewis, Chief Counsel, Head of Patient Advocacy, TAKEDA ONCOLOGY
Liz Lewis

Chief Counsel, Head of Patient Advocacy
TAKEDA ONCOLOGY

Casey Logan, CBO, TRACON PHARMACEUTICALS
Casey Logan

CBO
TRACON PHARMACEUTICALS

Timothy Lowinger, CSO, MERSANA THERAPEUTICS
Timothy Lowinger

CSO
MERSANA THERAPEUTICS

David Loynd, CEO, ENDURX PHARMACEUTICALS
David Loynd

CEO
ENDURX PHARMACEUTICALS

Krishna Menon, CSO and President of Research, CELLCEUTIX
Krishna Menon

CSO and President of Research
CELLCEUTIX

Michael Metzger, President and COO, SYNDAX
Michael Metzger

President and COO
SYNDAX

Ramon Mohanlal, CMO, BEYONDSPRING PHARMACEUTICALS
Ramon Mohanlal

CMO
BEYONDSPRING PHARMACEUTICALS

Jodie Morrison, CEO, TOKAI PHARMACEUTICALS
Jodie Morrison

CEO
TOKAI PHARMACEUTICALS

Rich Murray, CEO, JOUNCE THERAPEUTICS
Rich Murray

CEO
JOUNCE THERAPEUTICS

Shakti Narayan, Vice President, Head of Transactions, JOHNSON & JOHNSON
Shakti Narayan

Vice President, Head of Transactions
JOHNSON & JOHNSON

Melissa Nelson, Senior Global Project Manager, MEDTRONIC
Melissa Nelson

Senior Global Project Manager
MEDTRONIC

Sara Nochur, Senior Vice President, Regulatory Affairs, ALNYLAM PHARMACEUTICALS
Sara Nochur

Senior Vice President, Regulatory Affairs
ALNYLAM PHARMACEUTICALS

Denis Patrick, Executive Director, Head, External R&D Innovation, PFIZER
Denis Patrick

Executive Director, Head, External R&D Innovation
PFIZER

Carol Pitcher-Towner, Vice President, Regulatory Operations, ALNYLAM PHARMA
Carol Pitcher-Towner

Vice President, Regulatory Operations
ALNYLAM PHARMA

Matt Portch, Vice President, Managed Markets, SUNOVION
Matt Portch

Vice President, Managed Markets
SUNOVION

Amit Rakhit, CMO, OVID THERAPEUTICS
Amit Rakhit

CMO
OVID THERAPEUTICS

Chandra Ramanathan, Vice President and Head, East Coast Innovation Center,  BAYER
Chandra Ramanathan

Vice President and Head, East Coast Innovation Center
BAYER

Katie Reilly-Gauvin, Vice President, Global Commercial Development, ABBVIE
Katie Reilly-Gauvin

Vice President, Global Commercial Development
ABBVIE

Jane Rhodes, Senior Director, New Innovations, BIOGEN
Jane Rhodes

Senior Director, New Innovations
BIOGEN

Ron Robison, Vice President, Regulatory Quality and Safety, ABBVIE
Ron Robison

Vice President, Regulatory Quality and Safety
ABBVIE

Lindsay Rosenwald, CEO, FORTRESS BIOTECH
Lindsay Rosenwald

CEO
FORTRESS BIOTECH

Natalie Sacks, CMO, ADURO BIOTECH
Natalie Sacks

CMO
ADURO BIOTECH

Tehseen Salimi, Vice President, Medical Affairs, TREVENA
Tehseen Salimi

Vice President, Medical Affairs
TREVENA

Cynthia Schwalm, President, North American Commercial Operations, IPSEN
Cynthia Schwalm

President, North American Commercial Operations
IPSEN

David Sherris, CEO, GENADAM THERAPEUTICS,
David Sherris

CEO
GENADAM THERAPEUTICS

David Soergel, CMO, TREVENA
David Soergel

CMO
TREVENA

Jim Sullivan, Vice President, Discovery, ABBVIE
Jim Sullivan

Vice President, Discovery
ABBVIE

Steve Targum, CMO, FUNCTIONAL NEUROMODULATION
Steve Targum

CMO
FUNCTIONAL NEUROMODULATION

Charles Theuer, CEO, TRACON PHARMACEUTICALS
Charles Theuer

CEO
TRACON PHARMACEUTICALS

Doug Treco, CEO, RA PHARMACEUTICALS
Doug Treco

CEO
RA PHARMACEUTICALS

Maria Vilenchik, CEO, FELICITEX THERAPEUTICS
Maria Vilenchik

CEO
FELICITEX THERAPEUTICS

Sue Washer, CEO, APPLIED GENETIC TECHNOLOGIES CORPORATION
Sue Washer

CEO
APPLIED GENETIC TECHNOLOGIES CORPORATION

David Weinreich, Senior Vice President, Late Stage Clinical Development & Medical  Affairs, REGENERON
David Weinreich

Senior Vice President, Late Stage Clinical Development & Medical Affairs
REGENERON

Jeff Wiezorek, Senior Vice President, Clinical Development, KITE PHARMA
Jeff Wiezorek

Senior Vice President, Clinical Development
KITE PHARMA

Keith Wilcoxen, Senior Director, Scientific R&D, TESARO
Keith Wilcoxen

Senior Director, Scientific R&D
TESARO

Leslie Williams, CEO, IMMUSANT
Leslie Williams

CEO
IMMUSANT

Bryon Wornson, Vice President, Global Health and Value, PFIZER ONCOLOGY
Bryon Wornson

Vice President, Global Health and Value
PFIZER ONCOLOGY

Andrew Young, CSO, INTARCIA THERAPEUTICS
Andrew Young

CSO
INTARCIA THERAPEUTICS


Event Partners


Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives.

CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users who have experienced products and services firsthand and have an interest in letting other potential buyers their thoughts on their experience.


The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, education, research & development, and commercialization. The MLSC is charged with implementing a $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.


MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.


PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment.

pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.


PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.


PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.


Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas.





Please contact the event manager Marilyn below for the following:
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.

NO REFUNDS OR TRANSFER ALLOWED ON REGISTRATIONS
-----------------------------------------------------------------
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

SHU170502CEV

Share with friends

Date and Time

Location

Renaissance Boston Waterfront Hotel

606 Congress Street

Boston, MA 02210

View Map

Save This Event

Event Saved